Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143130
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2005-08-31
Brief Title:
Pregabalin In Partial Seizures Extension Study
Sponsor:
Pfizers Upjohn has merged with Mylan to form Viatris Inc
Organization:
Pfizer
Study Overview
Official Title:
Pregabalin in Partial Seizures PREPS Extension Study An 18-month Follow-on Open-label International Multicenter Add-on Therapy Trial
Status:
COMPLETED
Status Verified Date:
2015-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREPS EXT
Brief Summary:
To evaluate long-term efficacy and safety of pregabalin 150 to 600mgday as adjunctive treatment in patients with partial seizures
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None